Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - Observational study suggests a third dose of the Pfizer COVID-19 vaccine can prevent severe COVID-19-related outcomes, compared with only two doses received at least 5 months before.

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

Observational study suggests a third dose of the Pfizer COVID-19 vaccine can prevent severe COVID-19-related outcomes, compared with only two doses received at least 5 months before.

Zouhair Souissi

Bibliographie

31 octobre 2021

Soyez le premier à commenter!

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study – The Lancet Invited Commentary: Boosters appear effective, but are they always needed? – The Lancet Commentaries on Twitter Nice analysis of boosters in @TheLancet Fri.: https://t.co/KqXInFa3a9 But I want to highlight one number: […]

The post Observational study suggests a third dose of the Pfizer COVID-19 vaccine can prevent severe COVID-19-related outcomes, compared with only two doses received at least 5 months before. appeared first on Links Medicus.

Lu 741 fois